Company Filing History:
Years Active: 2012
Title: Bouwe Walsma: Innovator in Anhydrous Lactose Agglomerates
Introduction
Bouwe Walsma is a notable inventor based in Renkum, Netherlands. He has made significant contributions to the field of pharmaceutical excipients, particularly through his innovative work on anhydrous lactose agglomerates. His expertise and dedication to research have led to advancements that benefit moisture-sensitive applications in the pharmaceutical industry.
Latest Patents
Walsma holds a patent for "Anhydrous lactose agglomerates and the preparation thereof." This invention outlines a process for creating anhydrous lactose agglomerates, which involves subjecting essentially anhydrous lactose primary particles to a wet granulation step. The process operates at temperatures ranging from 30-100°C using a binder solution, ensuring that the granulation mass is dried during the granulation step. The resulting agglomerates contain at least 50 wt% lactose crystallites and maintain a total water content of 0-1.0 wt%, adhering to the standards set by the Pharmacopoeia for anhydrous lactose excipients. These agglomerates exhibit excellent compactibility and flowability properties, making them particularly useful in moisture-sensitive applications.
Career Highlights
Walsma is associated with Campina Nederland Holding B.V., where he continues to apply his expertise in the development of innovative solutions. His work has been instrumental in enhancing the quality and performance of pharmaceutical excipients, contributing to the overall efficacy of various medical formulations.
Collaborations
Walsma collaborates with Klaas Daniël Kussendrager, further enriching his research and development efforts. Their combined expertise fosters innovation and drives advancements in the field of pharmaceutical excipients.
Conclusion
Bouwe Walsma's contributions to the field of anhydrous lactose agglomerates exemplify the importance of innovation in pharmaceutical applications. His work not only enhances product quality but also supports the development of effective medical solutions.